BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 77724)

  • 21. Hemocytometer leukocyte adherence inhibition technique.
    Maluish AE; Halliday WJ
    Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
    Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
    J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Specific immunity in patients with carcinoma of the pancreas. Preliminary report].
    Mester M; Zuliani A; Scheinberg MA; Machado MC
    Rev Hosp Clin Fac Med Sao Paulo; 1983 Jun; 38(3):107-10. PubMed ID: 6364296
    [No Abstract]   [Full Text] [Related]  

  • 24. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
    Mounielou PM; Clemente F; Estival A; Ribet A
    Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic diagnosis of human digestive tract cancer. Carcinoembryonic antigens.
    Kamholz SL
    Am J Gastroenterol; 1973 Mar; 59(3):233-43. PubMed ID: 4121819
    [No Abstract]   [Full Text] [Related]  

  • 26. [Leukocyte adhesion inhibition to glass (LAI test) and early diagnosis of pancreatic carcinoma].
    Meduri F; Bizzarini M; Diana F; Gerunda G; Maffei-Faccioli A
    Minerva Chir; 1986 Aug; 41(15-16):1283-8. PubMed ID: 3774173
    [No Abstract]   [Full Text] [Related]  

  • 27. Selectivity of the micro-leukocyte adherence inhibition assay in pancreatic cancer.
    Douglass HO; Russo AJ; Howell JH; Moore MC; Arbuck SG; Chu TM; Goldrosen MH
    Cancer; 1979 Mar; 43(3):1084-8. PubMed ID: 371783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunodiagnosis of pancreatic cancer.
    Goldrosen MH; Campagnari A; Howell JH; Harvey S; Jenkins D; Berjian R; Douglass HO
    Prog Clin Biol Res; 1983; 133():167-82. PubMed ID: 6226048
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunodiagnosis of gastrointestinal tumors with the leukocyte adherence inhibition test].
    Stotz G; Liebe S; Storch H; Baehr R; Neumeister B
    Z Gesamte Inn Med; 1981 Feb; 36(3):suppl 225 contd. PubMed ID: 7013298
    [No Abstract]   [Full Text] [Related]  

  • 30. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oncofetal antigen].
    Nishida K; Yoshikawa T; Kondo M
    Nihon Rinsho; 1980; 38(1):152-60. PubMed ID: 6156250
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of a cancer screening test (ICP test)].
    Steen J; Vesth N
    Ugeskr Laeger; 1979 Jun; 141(25):1689-90. PubMed ID: 380098
    [No Abstract]   [Full Text] [Related]  

  • 33. Human cancers transplanted in nude mice retain the expression of their organ-specific neoantigens.
    Thomson DM; Neville AM; Phelan K; Scanzano RS; Vandevoorde JP
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1191-7. PubMed ID: 7199466
    [No Abstract]   [Full Text] [Related]  

  • 34. A modified leukocyte adherence inhibition test in the laboratory investigation of gastrointestinal cancer.
    Rutherford JC; Walters BA; Cavaye G; Halliday WJ
    Int J Cancer; 1977 Jan; 19(1):43-8. PubMed ID: 319065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
    Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
    Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human tumor-specific immunity assayed by a computerized tube leukocyte adherence inhibition.
    Thomson DM; Tataryn DN; Lopez M; Schwartz R; MacFarlane JK
    Cancer Res; 1979 Feb; 39(2 Pt 2):638-43. PubMed ID: 83918
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast, colorectal, stomach and pancreatic cancer.
    MacFarlane JK; Thomson DM; Phelan K; Shenouda G; Scanzano R
    Cancer; 1982 Mar; 49(6):1185-93. PubMed ID: 7037158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunodiagnosis of colorectal cancers by the leukocyte adherence inhibition test].
    Hudák J; Máriafoldy E; Nagy A; Szabó I; Baradnay G; Varga L
    Orv Hetil; 1983 Aug; 124(34):2045-7. PubMed ID: 6355968
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of a new immunoassay for determining serum pancreatic isoamylase with two standard techniques.
    Ventrucci M; Pezzilli R; Gullo L
    Am J Gastroenterol; 1990 Oct; 85(10):1381-5. PubMed ID: 2220732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of leukocyte adherence inhibition assay in early detection of breast cancer.
    Kovarík J; Lauerová L; Kudlicková Z; Ninger E; Zemanová D
    Arch Geschwulstforsch; 1981; 51(4):344-8. PubMed ID: 7032450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.